ClinVar Miner

Submissions for variant NM_000153.4(GALC):c.1251+5G>C

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002637386 SCV003513317 pathogenic Galactosylceramide beta-galactosidase deficiency 2024-09-19 criteria provided, single submitter clinical testing This sequence change falls in intron 11 of the GALC gene. It does not directly change the encoded amino acid sequence of the GALC protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs755870379, gnomAD 0.01%). This variant has been observed in individual(s) with Krabbe disease (internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2194917). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.